Sierra-Sánchez, V.M.; Blancas-Napoles, C.M.; Sánchez-Maldonado, A.D.; Medina, I.; Romero-Nava, R.; Huang, F.; Hong, E.; Aguilera-Méndez, A.; Ocampo-Ortega, S.A.; Villafaña, S.
Neuropilin-1: A Conserved Entry Receptor for SARS-CoV-2 and a Potential Therapeutic Target. Biomedicines 2025, 13, 1730.
https://doi.org/10.3390/biomedicines13071730
AMA Style
Sierra-Sánchez VM, Blancas-Napoles CM, Sánchez-Maldonado AD, Medina I, Romero-Nava R, Huang F, Hong E, Aguilera-Méndez A, Ocampo-Ortega SA, Villafaña S.
Neuropilin-1: A Conserved Entry Receptor for SARS-CoV-2 and a Potential Therapeutic Target. Biomedicines. 2025; 13(7):1730.
https://doi.org/10.3390/biomedicines13071730
Chicago/Turabian Style
Sierra-Sánchez, Vivany Maydel, Citlali Margarita Blancas-Napoles, Aina Daniela Sánchez-Maldonado, Indira Medina, Rodrigo Romero-Nava, Fengyang Huang, Enrique Hong, Asdrúbal Aguilera-Méndez, Sergio Adrian Ocampo-Ortega, and Santiago Villafaña.
2025. "Neuropilin-1: A Conserved Entry Receptor for SARS-CoV-2 and a Potential Therapeutic Target" Biomedicines 13, no. 7: 1730.
https://doi.org/10.3390/biomedicines13071730
APA Style
Sierra-Sánchez, V. M., Blancas-Napoles, C. M., Sánchez-Maldonado, A. D., Medina, I., Romero-Nava, R., Huang, F., Hong, E., Aguilera-Méndez, A., Ocampo-Ortega, S. A., & Villafaña, S.
(2025). Neuropilin-1: A Conserved Entry Receptor for SARS-CoV-2 and a Potential Therapeutic Target. Biomedicines, 13(7), 1730.
https://doi.org/10.3390/biomedicines13071730
